Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2016, Article ID 1872627, 10 pages
http://dx.doi.org/10.1155/2016/1872627
Research Article

The Role of Pulmonary Veins in Cancer Progression from a Computed Tomography Viewpoint

1Division of Hemato-Oncology, Department of Internal Medicine, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan
2Division of Cardiology, Department of Internal Medicine, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan
3Division of Chest, Department of Internal Medicine, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan
4Department of Medical Imaging and Intervention and Department of Internal Medicine, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan

Received 20 April 2016; Accepted 25 August 2016

Academic Editor: Sofia D. Merajver

Copyright © 2016 Chuang-Chi Liaw et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. V. Porres, Ó. P. Morenza, E. Pallisa, A. Roque, J. Andreu, and M. Martínez, “Learning from the pulmonary veins,” RadioGraphics, vol. 33, no. 4, pp. 999–1022, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-T. Lin, S.-C. Ku, M.-Z. Wu, and C.-J. Yu, “Intracardiac extension of lung cancer via the pulmonary vein,” Thorax, vol. 63, no. 12, p. 1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Dore, M. Alerci, F. D'Andrea, G. D. Giulio, A. D. Agostini, and G. Volpato, “Intracardiac extension of lung cancer via pulmonary veins: CT diagnosis,” Journal of Computer Assisted Tomography, vol. 12, no. 4, pp. 565–568, 1988. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-C. Liaw, H. Chang, T.-S. Yang, and M.-S. Wen, “Pulmonary venous obstruction in cancer patients,” Journal of Oncology, vol. 2015, Article ID 210916, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Dranoff, “Cytokines in cancer pathogenesis and cancer therapy,” Nature Reviews Cancer, vol. 4, no. 1, pp. 11–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. W. Dudek and T. M. Louis, High-Yield Gross Anatomy, Lippincott Williams & Wilkins, London, UK, 5th edition, 2014.
  7. W. Sienel, R. Seen-Hibler, W. Mutschler, K. Pantel, and B. Passlick, “Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance,” The European Journal of Cardio-Thoracic Surgery, vol. 23, no. 4, pp. 451–456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. K. G. Phillips, A. M. Lee, G. W. Tormoen et al., “The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation,” The American Journal of Physiology Cell Physiology, vol. 308, no. 3, pp. C229–C236, 2015. View at Publisher · View at Google Scholar
  9. M. Hashimoto, F. Tanaka, K. Yoneda et al., “Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer,” Interactive Cardiovascular and Thoracic Surgery, vol. 18, no. 6, pp. 775–783, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. B. N. Smith and N. A. Bhowmick, “Role of EMT in metastasis and therapy resistance,” Journal of Clinical Medicine, vol. 5, no. 2, p. 17, 2016. View at Publisher · View at Google Scholar
  11. K. R. Fischer, A. Durrans, S. Lee et al., “Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance,” Nature, vol. 527, no. 7579, pp. 472–476, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Heerboth, G. Housman, M. Leary et al., “EMT and tumor metastasis,” Clinical and Translational Medicine, vol. 4, no. 1, article 6, 2015. View at Publisher · View at Google Scholar
  13. J. Pasquier, N. Abu-Kaoud, H. Al Thani, and A. Rafii, “Epithelial to mesenchymal transition in a clinical perspective,” Journal of Oncology, vol. 2015, Article ID 792182, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Papageorgis, “TGFβ signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis,” Journal of Oncology, vol. 2015, Article ID 587193, 15 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Landskron, M. De La Fuente, P. Thuwajit, C. Thuwajit, and M. A. Hermoso, “Chronic inflammation and cytokines in the tumor microenvironment,” Journal of Immunology Research, vol. 2014, Article ID 149185, 19 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. J. Schwarzbach, A. Schaefer, A. Ebert et al., “Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology,” Stroke, vol. 43, no. 11, pp. 3029–3034, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. Álvarez-Pérez, I. Verde, M. Usón-Martín, A. Figuerola-Roig, J. Ballabriga-Planas, and A. Espino-Ibañez, “Frequency and mechanism of ischemic stroke associated with malignancy: a retrospective series,” European Neurology, vol. 68, no. 4, pp. 209–213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. I. Ripamonti, D. Santini, E. Maranzano, M. Berti, and F. Roila, “Management of cancer pain: ESMO clinical practice guidelines,” Annals of Oncology, vol. 23, supplement 7, pp. vii139–vii154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. C. Chang and H. M. Gross, “Neoplastic fever responds to the treatment of an adequate dose of naproxen,” Journal of Clinical Oncology, vol. 3, no. 4, pp. 552–558, 1985. View at Google Scholar · View at Scopus
  20. K. C. Fearon, A. C. Voss, and D. S. Hustead, “Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis,” The American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1345–1350, 2006. View at Google Scholar · View at Scopus
  21. C. N. Bagot and R. Arya, “Virchow and his triad: a question of attribution,” British Journal of Haematology, vol. 143, no. 2, pp. 180–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Wolberg, M. M. Aleman, K. Leiderman, and K. R. Machlus, “Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited,” Anesthesia & Analgesia, vol. 114, no. 2, pp. 275–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Falanga, M. Marchetti, and A. Vignoli, “Coagulation and cancer: biological and clinical aspects,” Journal of Thrombosis and Haemostasis, vol. 11, no. 2, pp. 223–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Margetic, “Inflammation and haemostasis,” Biochemia Medica, vol. 22, no. 1, pp. 49–62, 2012. View at Google Scholar · View at Scopus
  25. M. Levi and T. van der Poll, “Inflammation and coagulation,” Critical Care Medicine, vol. 38, no. 2, supplement, pp. S26–S34, 2010. View at Publisher · View at Google Scholar
  26. G. H. Lyman, L. Eckert, Y. Wang, H. Wang, and A. Cohen, “Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis,” Oncologist, vol. 18, no. 12, pp. 1321–1329, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. R. M. Reddy, V. Murlidhar, L. Zhao et al., “Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer,” The Journal of Thoracic and Cardiovascular Surgery, vol. 151, no. 3, pp. 852–858, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Parent, S. Maître, G. Meyer et al., “Diagnostic value of D-dimer in patients with suspected pulmonary embolism: results from a multicentre outcome study,” Thrombosis Research, vol. 120, no. 2, pp. 195–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Kanz, T. Vukovich, R. Vormittag et al., “Thrombosis risk and survival in cancer patients with elevated C-reactive protein,” Journal of Thrombosis and Haemostasis, vol. 9, no. 1, pp. 57–63, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. I. J. Fidler, “The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited,” Nature Reviews Cancer, vol. 3, no. 6, pp. 453–458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Iguchi, K. Kimura, K. Kobayashi, Y. Ueno, and T. Inoue, “Ischaemic stroke with malignancy may often be caused by paradoxical embolism,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 77, no. 12, pp. 1336–1339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Oshimori, D. Oristian, and E. Fuchs, “TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma,” Cell, vol. 160, no. 5, pp. 963–976, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. S. R. El Azab, P. M. J. Rosseel, J. J. de Lange et al., “Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery,” The British Journal of Anaesthesia, vol. 88, no. 4, pp. 496–501, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Ettelaie, D. Fountain, M. E. W. Collier, A. M. ElKeeb, Y. P. Xiao, and A. Maraveyas, “Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1812, no. 12, pp. 1591–1600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. I. J. Elenkov and G. P. Chrousos, “Stress, cytokine patterns and susceptibility to disease,” Bailliere's Best Practice & Research in Clinical Endocrinology and Metabolism, vol. 13, no. 4, pp. 583–595, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Buyue, T. M. Misenheimer, and J. P. Sheehan, “Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism,” The Journal of Thrombosis and Haemostasis, vol. 10, no. 10, pp. 2086–2098, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. G.-X. Zhong, Y. Gong, C.-J. Yu et al., “Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism,” Tumor Biology, vol. 36, no. 6, pp. 4689–4697, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. P. J. Sarvaiya, D. Guo, I. Ulasov, P. Gabikian, and M. S. Lesniak, “Chemokines in tumor progression and metastasis,” Oncotarget, vol. 4, no. 12, pp. 2171–2185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Scotté, J. B. Rey, and V. Launay-Vacher, “Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads,” Supportive Care in Cancer, vol. 20, no. 12, pp. 3033–3042, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. L. Bick, “Cancer-associated thrombosis: focus on extended therapy with dalteparin,” Journal of Supportive Oncology, vol. 4, no. 3, pp. 115–120, 2006. View at Google Scholar · View at Scopus
  41. M. Carrier and A. Y. Y. Lee, “Thromboprophylaxis in cancer patients,” Seminars in Thrombosis and Hemostasis, vol. 40, no. 3, pp. 395–400, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Falanga, A. Vignoli, E. Diani, and M. Marchetti, “Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival,” Patient Related Outcome Measures, vol. 2, pp. 175–188, 2011. View at Google Scholar
  43. L. Pusztai, T. R. Mendoza, J. M. Reuben et al., “Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy,” Cytokine, vol. 25, no. 3, pp. 94–102, 2004. View at Publisher · View at Google Scholar · View at Scopus